Search Our Scientific Publications & Authors

Publications
find publications by category +
Translate page:

Assessment of health-related quality of life in cancer patients undergoing treatment using Health Utilities Index (HUI-3) in east Delhi, India.

Authors:
Utsav Gupta Madhu K Upadhyay Rahul Sharma

Indian J Cancer 2021 May 11. Epub 2021 May 11.

Department of Community Medicine, University College of Medical Sciences and Guru Teg Bahadur Hospital, New Delhi, India.

Background: Health-related quality of life (HRQOL) is a construct that focuses on the capacity for living afforded by the health status of a patient. Measurement of HRQOL allows a composite estimation of the capacity for living of a patient and can help capture the suffering experienced by the patient due to adverse effects of therapeutic interventions. This study was conducted to understand the health-related quality of life of cancer patients undergoing various modalities of treatment to generate evidence source for need-based intervention, to assess patients diagnosed with cancers, using Health Utilities Index - 3 (HUI-3) and assign them single-score values to gauge HRQOL and to measure the various domains of HRQOL and change in HRQOL after a period of three months of treatment.

Methods: A descriptive, longitudinal study was conducted amongst patients aged more than 18 years, who were diagnosed with cancer at a tertiary care multispecialty hospital in New Delhi. They were administered a standardized HUI-3 Questionnaire and their responses were recorded, simultaneously. Statistical significance for change in HRQOL score was assessed with paired t-test. Multivariate linear regression was used to identify the various correlates of HRQOL.

Results: The mean (± standard deviation) overall HRQOL score for all participants was 0.71 (± 0.262) [range=-0.09 to 1.00]. A follow-up assessment was carried out after three months and changes in health scores were subsequently recorded. A significant decrease in mean overall HRQOL score was seen for the entire group after three months of having been administered treatment. Single-attributes of emotion and ambulation were maximally affected amongst cancer patients after three months of treatment. On linear regression analyses, baseline HRQOL was a significant correlate of HRQOL at follow-up after three months.

Conclusion: : Addressing the HRQOL of a cancer patient before starting treatment would address morbidity that might be present even after three months.

Download full-text PDF

 Source
http://dx.doi.org/10.4103/ijc.IJC_1079_19DOI Listing
May 2021

Publication Analysis

Top Keywords

three months
20
hrqol score
12
health-related quality
12
quality life
12
cancer patients
12
hrqol
11
study conducted
8
utilities hui-3
8
health utilities
8
change hrqol
8
capacity living
8
patients undergoing
8
linear regression
8
life cancer
8
three
6
patients
5
cancer
5
months
5
treatment
5
simultaneously statistical
4

Keyword Occurance

Similar Publications

Management of hydronephrosis after radical cystectomy and urinary diversion for bladder cancer: A single tertiary center experience.

Authors:
Toshiaki Tanaka Tetsuya Shindo Kohei Hashimoto Ko Kobayashi Naoya Masumori

Int J Urol 2022 Jun 30. Epub 2022 Jun 30.

Department of Urology, Sapporo Medical University, Sapporo, Hokkaido, Japan.

Objectives: To clarify the incidence of postoperative hydronephrosis and verify the validity of diagnostic and therapeutic approaches for hydronephrosis after cystectomy and urinary diversion for bladder cancer.

Methods: Totally, 290 patients receiving urinary diversion from 2005 through 2017 with complete data were enrolled, including 258 (89.0%) with an ileal conduit and 32 (11. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Magnetic Resonance Imaging and Histopathology of Catheter Ablation Lesions after Ventricular Tachycardia Ablation in Patients with Nonischemic Cardiomyopathy.

Authors:
Michael Ghannam Jackson Liang Anil Attili Hubert Cochet Pierre Jais Rakesh Latchamsetty Krit Jongnarangsin Fred Morady David Gordon Frank Bogun

Heart Rhythm 2022 Jun 27. Epub 2022 Jun 27.

Division of Cardiovascular Medicine. Electronic address:

Background: Late gadolinium enhanced cardiac magnetic resonance (LGE-CMR) imaging may help identify radiofrequency ablation lesions. This has been poorly described in patients with non-ischemic cardiomyopathy (NICM).

Objectives: To describe LGE-CMR characteristics of ablation lesions in patients with NICM and correlate with histopathology. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.

Authors:
Amanda Jane Leach Nicole Wilson Beth Arrowsmith Jemima Beissbarth Edward Kim Mulholland Mathuram Santosham Paul John Torzillo Peter McIntyre Heidi Smith-Vaughan Mark D Chatfield Deborah Lehmann Michael Binks Anne B Chang Jonathan Carapetis Vicki Krause Ross Andrews Tom Snelling Sue A Skull Paul V Licciardi Victor M Oguoma Peter Stanley Morris

Lancet Infect Dis 2022 Jun 27. Epub 2022 Jun 27.

Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, NT, Australia; Royal Darwin Hospital, Paediatrics Department, Darwin, NT, Australia.

Background: Australian First Nations children are at very high risk of early, recurrent, and persistent bacterial otitis media and respiratory tract infection. With the PREVIX randomised controlled trials, we aimed to evaluate the immunogenicity of novel pneumococcal conjugate vaccine (PCV) schedules.

Methods: PREVIX_BOOST was a parallel, open-label, outcome-assessor-blinded, randomised controlled trial. Read More

View Article and Full-Text PDF
June 2022
Similar Publications

SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial.

Authors:
Yuqin Song Yanyan Liu Zhi-Ming Li Lanfang Li Hang Su Zhengming Jin Xuelan Zuo Jianyuan Wu Hui Zhou Kunyan Li Chuan He Jianfeng Zhou Junyuan Qi Siguo Hao Zhen Cai Yijing Li Weiwei Wang Xiaojing Zhang Jianjun Zou Jun Zhu

Lancet Haematol 2022 Jul;9(7):e493-e503

Key Laboratory of Carcinogenesis and Transitional Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China. Electronic address:

Background: Dysregulation of EZH2 has a crucial role in lymphomagenesis. We did a first-in-human study to assess the safety, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of SHR2554, an oral EZH2 inhibitor, in patients with relapsed or refractory mature lymphoid neoplasms, including B-cell lymphomas, T-cell lymphomas, and classical Hodgkin lymphoma.

Methods: This was a multicentre, dose-escalation, dose-expansion, and clinical expansion phase 1 study done at 13 hospitals in China. Read More

View Article and Full-Text PDF
July 2022
Similar Publications

Daily and on-demand HIV pre-exposure prophylaxis with emtricitabine and tenofovir disoproxil (ANRS PREVENIR): a prospective observational cohort study.

Authors:
Jean-Michel Molina Jade Ghosn Lambert Assoumou Constance Delaugerre Michèle Algarte-Genin Gilles Pialoux Christine Katlama Laurence Slama Geoffroy Liegeon Lydie Beniguel Michel Ohayon Hanane Mouhim Lauriane Goldwirt Bruno Spire Bénédicte Loze Laure Surgers Juliette Pavie Jérémy Lourenco Mohamed Ben-Mechlia Soizic Le Mestre Daniela Rojas-Castro Dominique Costagliola

Lancet HIV 2022 Jun 27. Epub 2022 Jun 27.

Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.

Background: There are few data available regarding the use of on-demand pre-exposure prophylaxis (PrEP) for HIV prevention. We aimed to assess PrEP effectiveness, adherence, and safety in adults using daily or on-demand PrEP.

Methods: We conducted a prospective observational cohort study (ANRS PREVENIR) at 26 sites in the Paris region, France. Read More

View Article and Full-Text PDF
June 2022
Similar Publications
}